Trichostatin A Alleviates Renal Interstitial Fibrosis Through Modulation of the M2 Macrophage Subpopulation
Open Access
- 19 August 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (17) , 5966
Abstract
Mounting evidence indicates that an increase in histone deacetylation contributes to renal fibrosis. Although inhibition of histone deacetylase (HDAC) can reduce the extent of fibrosis, whether HDAC inhibitors exert the antifibrotic effect through modulating the phenotypes of macrophages, the key regulator of renal fibrosis, remains unknown. Moreover, the functional roles of the M2 macrophage subpopulation in fibrotic kidney diseases remain incompletely understood. Herein, we investigated the role of HDAC inhibitors on renal fibrogenesis and macrophage plasticity. We found that HDAC inhibition by trichostatin A (TSA) reduced the accumulation of interstitial macrophages, suppressed the activation of myofibroblasts and attenuated the extent of fibrosis in obstructive nephropathy. Moreover, TSA inhibited M1 macrophages and augmented M2 macrophage infiltration in fibrotic kidney tissue. Interestingly, TSA preferentially upregulated M2c macrophages and suppressed M2a macrophages in the obstructed kidneys, which was correlated with a reduction of interstitial fibrosis. TSA also repressed the expression of proinflammatory and profibrotic molecules in cultured M2a macrophages and inhibited the activation of renal myofibroblasts. In conclusion, our study was the first to show that HDAC inhibition by TSA alleviates renal fibrosis in obstructed kidneys through facilitating an M1 to M2c macrophage transition.Keywords
Funding Information
- Taipei Veterans General Hospital (V105C-013, V106C-147, V107C-127, V107-B-037, V108-C-175, V108-C-103)
- Ministry of Science and Technology, Taiwan (MOST 102-2314-B-010-004-MY3, MOST 105-2314-B-010-016, MOST 106-2314-B-010-039-MY3, MOST 107-2314-B-075-064-MY3)
- Department of Health, Taipei City Government (10401-62-010, 10501-62-006)
This publication has 28 references indexed in Scilit:
- High burden and unmet patient needs in chronic kidney diseaseInternational Journal of Nephrology and Renovascular Disease, 2012
- Valproic Acid Attenuates Proteinuria and Kidney InjuryJournal of the American Society of Nephrology, 2011
- Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptorKidney International, 2011
- Mechanisms of Tubulointerstitial FibrosisJournal of the American Society of Nephrology, 2010
- Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injuryAmerican Journal of Physiology-Renal Physiology, 2010
- Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathyAmerican Journal of Physiology-Renal Physiology, 2009
- Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathyKidney International, 2009
- Macrophage diversity in renal injury and repairJournal of Clinical Investigation, 2008
- All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in TaiwanThe Lancet, 2008
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004